Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action

Theresa Gillis, Megan Crane, Carly Hinkle, Nathan Wei Arthritis Treatment Center, Frederick, MD, USA Objective: Many types of treatment are available for patients with rheumatoid arthritis (RA), however, some patients fail to achieve remission. This report aims to determin...

Full description

Bibliographic Details
Main Authors: Gillis T, Crane M, Hinkle C, Wei N
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Open Access Rheumatology: Research and Reviews
Subjects:
Online Access:https://www.dovepress.com/repository-corticotropin-injection-as-adjunctive-therapy-in-patients-w-peer-reviewed-article-OARRR
_version_ 1818739220091502592
author Gillis T
Crane M
Hinkle C
Wei N
author_facet Gillis T
Crane M
Hinkle C
Wei N
author_sort Gillis T
collection DOAJ
description Theresa Gillis, Megan Crane, Carly Hinkle, Nathan Wei Arthritis Treatment Center, Frederick, MD, USA Objective: Many types of treatment are available for patients with rheumatoid arthritis (RA), however, some patients fail to achieve remission. This report aims to determine the safety and efficacy of using repository corticotropin injection (RCI) as an adjunctive therapy in patients with RA refractory to at least three therapeutics with different mechanisms of action. Method: In this open-label, interventional, single-group study, patients received 80 U RCI twice weekly via subcutaneous injection over 12 weeks. Changes in the Ritchie–Camp Articular Index and health assessment questionnaire scores were monitored for changes from baseline measures. Results: Eight patients were enrolled and consisted of seven females and one male with an average age of 64.6 years and disease duration of 20.9 years. Use of RCI resulted in significant improvement in swollen and tender joint counts. The disease activity score 28 and the physician and patient visual analog scale scores were significantly reduced at treatment week 12. The reduction in health assessment questionnaire scores did not reach statistical significance after RCI treatment. Once RCI therapy was discontinued, all improvements in disease activity score 28, physician and patient visual analog scale, and tender and swollen joint counts achieved during treatment were lost by the week 16 follow-up visit. Conclusion: While larger clinical trials are necessary to further confirm the efficacy of RCI in patients with refractory RA, the response of patients with refractory RA in this study suggests that RCI can be an effective add-on therapy for patients who have exhausted several classes of treatments. Furthermore, this study suggests that RCI has an alternative mode of action, compared to other available antirheumatic drugs. Keywords: refractory rheumatoid arthritis, rheumatoid arthritis, adrenocorticotropic hormone, repository corticotropin injection
first_indexed 2024-12-18T01:21:22Z
format Article
id doaj.art-2a53c5322b2446e79e3ff820d1709e0b
institution Directory Open Access Journal
issn 1179-156X
language English
last_indexed 2024-12-18T01:21:22Z
publishDate 2017-07-01
publisher Dove Medical Press
record_format Article
series Open Access Rheumatology: Research and Reviews
spelling doaj.art-2a53c5322b2446e79e3ff820d1709e0b2022-12-21T21:25:50ZengDove Medical PressOpen Access Rheumatology: Research and Reviews1179-156X2017-07-01Volume 913113833832Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of actionGillis TCrane MHinkle CWei NTheresa Gillis, Megan Crane, Carly Hinkle, Nathan Wei Arthritis Treatment Center, Frederick, MD, USA Objective: Many types of treatment are available for patients with rheumatoid arthritis (RA), however, some patients fail to achieve remission. This report aims to determine the safety and efficacy of using repository corticotropin injection (RCI) as an adjunctive therapy in patients with RA refractory to at least three therapeutics with different mechanisms of action. Method: In this open-label, interventional, single-group study, patients received 80 U RCI twice weekly via subcutaneous injection over 12 weeks. Changes in the Ritchie–Camp Articular Index and health assessment questionnaire scores were monitored for changes from baseline measures. Results: Eight patients were enrolled and consisted of seven females and one male with an average age of 64.6 years and disease duration of 20.9 years. Use of RCI resulted in significant improvement in swollen and tender joint counts. The disease activity score 28 and the physician and patient visual analog scale scores were significantly reduced at treatment week 12. The reduction in health assessment questionnaire scores did not reach statistical significance after RCI treatment. Once RCI therapy was discontinued, all improvements in disease activity score 28, physician and patient visual analog scale, and tender and swollen joint counts achieved during treatment were lost by the week 16 follow-up visit. Conclusion: While larger clinical trials are necessary to further confirm the efficacy of RCI in patients with refractory RA, the response of patients with refractory RA in this study suggests that RCI can be an effective add-on therapy for patients who have exhausted several classes of treatments. Furthermore, this study suggests that RCI has an alternative mode of action, compared to other available antirheumatic drugs. Keywords: refractory rheumatoid arthritis, rheumatoid arthritis, adrenocorticotropic hormone, repository corticotropin injectionhttps://www.dovepress.com/repository-corticotropin-injection-as-adjunctive-therapy-in-patients-w-peer-reviewed-article-OARRRRefractory rheumatoid arthritisrheumatoid arthritisadrenocorticotropic hormonerepository corticotropin injection
spellingShingle Gillis T
Crane M
Hinkle C
Wei N
Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action
Open Access Rheumatology: Research and Reviews
Refractory rheumatoid arthritis
rheumatoid arthritis
adrenocorticotropic hormone
repository corticotropin injection
title Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action
title_full Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action
title_fullStr Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action
title_full_unstemmed Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action
title_short Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action
title_sort repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action
topic Refractory rheumatoid arthritis
rheumatoid arthritis
adrenocorticotropic hormone
repository corticotropin injection
url https://www.dovepress.com/repository-corticotropin-injection-as-adjunctive-therapy-in-patients-w-peer-reviewed-article-OARRR
work_keys_str_mv AT gillist repositorycorticotropininjectionasadjunctivetherapyinpatientswithrheumatoidarthritiswhohavefailedprevioustherapieswithatleastthreedifferentmodesofaction
AT cranem repositorycorticotropininjectionasadjunctivetherapyinpatientswithrheumatoidarthritiswhohavefailedprevioustherapieswithatleastthreedifferentmodesofaction
AT hinklec repositorycorticotropininjectionasadjunctivetherapyinpatientswithrheumatoidarthritiswhohavefailedprevioustherapieswithatleastthreedifferentmodesofaction
AT wein repositorycorticotropininjectionasadjunctivetherapyinpatientswithrheumatoidarthritiswhohavefailedprevioustherapieswithatleastthreedifferentmodesofaction